November 8, 2024 – Dizal (SSE:688192), a biopharmaceutical company committed to developing novel...
Author - David Miller
Number of Family Caregivers Supporting Older Adults Increasing
THURSDAY, Feb. 20, 2025 -- From 2011 to 2022, there was an increase in the number of family...
Neurotech Provides Update on BLA for NT-501 as a Treatment for...
Cumberland, R.I., November 8, 2024 (BUSINESS WIRE) – Neurotech Pharmaceuticals, Inc., an...
Systolic BP Target
FRIDAY, Feb. 21, 2025 -- Most older adults in the Systolic Blood Pressure Intervention Trial...
Diabetes, Dyslipidemia Screening Rates Low After Pregnancy, Even...
FRIDAY, Feb. 21, 2025 -- Patients with pregnancy-related hypertension (HTN) or diabetes are more...
Unicycive Therapeutics Announces U.S. FDA Acceptance of the New...
LOS ALTOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq:...
Certain Glucose-Lowering Meds Associated With Lower Risk for...
FRIDAY, Feb. 21, 2025 -- For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary...
Aldeyra Therapeutics Announces FDA Acceptance for Review of...
LEXINGTON, Mass.–(BUSINESS WIRE)–Nov. 18, 2024– Aldeyra Therapeutics, Inc...
Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission...
CLEVELAND, Nov. 12, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today...
Datopotamab Deruxtecan New BLA Submitted for Accelerated...
12 November 2024 — AstraZeneca and Daiichi Sankyo have submitted a new Biologics License...